
GLP-3 RT (LY3437943), is a synthetic research peptide consisting of 39 amino acids. This novel compound functions as a triple receptor agonist, simultaneously targeting glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptors. The peptide’s unique molecular structure adopts a single continuous helical conformation, enabling multi-receptor engagement for advanced research applications.